R1 RCM Inc. leverages technology to provide solutions that both optimize the patient experience and bolster the financial performance of hospitals, health ...
R1 RCM Inc. is a leading provider of revenue cycle management (RCM) services for the healthcare industry. Founded in 2003 and headquartered in Murray, Utah, the company specializes in leveraging technology—including AI, automation, and data analytics—to streamline the complex financial operations of medical groups and large health systems. Its core ...R1 RCM Inc. is a leading provider of revenue cycle management (RCM) services for the healthcare industry. Founded in 2003 and headquartered in Murray, Utah, the company specializes in leveraging technology—including AI, automation, and data analytics—to streamline the complex financial operations of medical groups and large health systems. Its core mission is to help providers capture revenue, optimize clinical documentation, and manage billing and coding processes with greater efficiency.
From a business perspective, R1 operates as an essential partner to healthcare providers, managing end-to-end revenue cycles that include patient access, registration, charge capture, and insurance claims processing. By offloading these non-clinical, administrative burdens to R1, hospitals can focus more effectively on patient care while improving their overall financial health. The company’s service portfolio is broad, spanning physician advisory services, practice management, revenue integrity, and cloud-based patient scheduling platforms.
Financially, R1 RCM maintains a significant market presence with a market capitalization exceeding $6 billion. The company’s financial structure reflects a capital-intensive service model, supported by large-scale enterprise deployments across the U.S. healthcare landscape. Recent financial data indicates an enterprise value of approximately $7.6 billion, with a focus on scaling digital capabilities to reduce reliance on manual labor, as evidenced by their 'Digital Transformation Office' initiatives. Key metrics show a stable current ratio and a commitment to operational efficiency, although the firm navigates complex debt structures, as seen in its recent acquisition by private equity interests TowerBrook Capital Partners and Clayton, Dubilier & Rice.
Key leadership, including CEO Joe Flanagan, emphasizes the transition toward 'agentic AI' and intelligent automation to address the rising costs of healthcare administration. The company’s long-term strategy focuses on digitizing the back-office, enhancing the patient experience through modern SaaS solutions, and maintaining strong partnerships with leading U.S. health systems. Despite challenges related to the macro-economic environment and the integration of large-scale acquisitions, R1 RCM remains a dominant player in the healthcare information services sector, characterized by its deep domain expertise and a workforce of over 26,000 employees dedicated to optimizing the 'financial anatomy' of healthcare.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$2.3B
+24.8%
+4.6%
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$3.3M
+105.7%
-161.8%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
+21.5%
+7.5%
-12.1%
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
+6.6%
+3850.6%
-76.2%
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
+0.1%
+104.6%
-150.3%
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$237.6M
+329.8%
+842.2%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
+10.5%
+284.1%
+800.7%
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
63.3%
-9.4%
-2.0%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
1.83x
+13.4%
-2.6%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
Operator: Thank you for standing by. My name is Eric, and I will be your conference operator today. At this time, I would like to welcome everyone to the Second Quarter 2024 R1 RCM Inc. Earnings Conference Call. [Operator Instructions]. I would now like to turn the call over to Evan Smith. Please go ahead.
Evan Smith: Thank you, operator. Certain statements made during this call may be considered forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In particular, any statements about our future growth plans and performance statements about the impacts of recent cyberattacks, including the Change Healthcare and Ascension cyberattacks on our business and financial results, our strategic and cost-saving initiatives, our liquidity position, our integration, our growth opportunities, our future financial performance are forward-looking statements. These statements are often identified by the use of words such as anticipate, believe, estimate, intend, design, may, plan, project, would and similar expressions or variations. Investors are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements made on today's call involve risks and uncertainties. While we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. Our actual results and outcomes may differ materially from those included in these forward-looking statements as a result of various factors, including but not limited to, the completion of the take-private transaction announced on August 1, 2024, on anticipated terms and timing or at all; breaches or failures of our vendors' information security measures or unauthorized access to a customer's data; disruptions in or damages to our global business service centers, third-party operated data centers or other services provided by other third parties economic downturns and market conditions beyond our control, including high inflation; the quality of global financial markets our ability to timely and successfully achieve the anticipated benefits and potential synergies of the acquisitions of Cloudmed and Acclara; our ability to retain existing customers or acquire new customers; the development of markets for our revenue cycle management offering; variability in the lead time of prospective customers; delayed or unsuccessful implementation of our technologies, including AI; competition with the market and the factors discussed under the heading Risk Factors in our most recent annual report on Form 10-K. Certain results will be referenced on this call may be rounded to the nearest whole number. We will also be referencing non-GAAP metrics on this call. For reconciliation of non-GAAP metrics to the most closely comparable GAAP metrics, please refer to our press release. As a reminder, last week, we announced the execution …
